Skip to main content
Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
577.30
-8.91 (-1.52%)
Dec 5, 2025, 4:00 PM EST - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
 Dec '24 Dec '12 Dec '11 Dec '10 Dec '09 2017 - 2019
Novel Therapeutics
180.13M
Log In
Log In
Log In
Log In
Upgrade
Novel Therapeutics Growth
122439.46%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
 Dec '24 Dec '12 Dec '11 Dec '10 Dec '09 2017 - 2019
United States
180.13M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
122439.46%
Log In
Log In
Log In
Log In
Upgrade